Tranexamic Acid Dosing for Total Joint Arthroplasty
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of increasing doses of tranexamic acid
(TXA) on limiting blood loss during total knee and total hip arthroplasty as defined by a
change in hemoglobin from pre-operative baseline to the first post-operative day.